Avera Cancer Institute - Mitchell (Site 0121)

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Prostate cancer2 trials

Phase

• Phase 32 trials

Status

• Recruiting2 trials

Lead sponsor

• Merck Sharp & Dohme LLC2 trials

Running trials

• Recruiting

  Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

  NCT06136624· Phase 3· Merck Sharp & Dohme LLC· Source

  Contact: Study Coordinator

• Recruiting

  A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  NCT06136650· Phase 3· Merck Sharp & Dohme LLC· Source

  Contact: Study Coordinator

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Prostate cancer2 recruiting